← Evidence map

ArticleCancers2026

Comparative Evaluation of Sentinel Lymph Node Detection Rates in Breast Cancer Surgery: "ICG + Patent Blue" Versus "99mTc + Patent Blue", a 11-Year Single-Center Study.

Ines Hfaiedh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Comparative Evaluation of Sentinel Lymph Node Detection Rates in Breast Cancer Surgery: "ICG + Patent Blue" Versus "99mTc + Patent Blue", a 11-Year Single-Center Study. | OpenQuestion